🔗 Share this article

An underground economy for unapproved weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid British shipping. Sellers promote the drug there before directing buyers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in users injecting substances of uncertain source.

Several experts said the popularity for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Service Reaction and Content Removal

Based on the social media company, the service has removed violative content and banned related hashtags and query recommendations. The organization stated it was committed to maintaining the service secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also found communities with up to nine thousand participants marketing retatrutide using the platform's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, populated with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.

Within minutes of entering one group, a vendor shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Item Details and Pricing

Within these communities, posts display black plastic packages with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Safety Measures

A representative for Telegram stated it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Although the science behind this drug is valid, these online products may not contain what they advertise,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service connected the increase in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, patients are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her team has previously encountered patients harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose users to potentially serious health risks”.